Biogen Inc (NASDAQ:BIIB)
| 277.88 BATS BZX Real-Time Price As of 12:55pm ET |  -2.44 / -0.87%Today’s Change | 223.25 Today|||52-Week Range 374.99 | +13.49% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 280.32 |
| Today’s open | 279.99 |
| Day’s range | 277.17 - 282.25 |
| Volume | 62,811 |
| Average volume (3 months) | 1,558,508 |
| Market cap | $38.9B |
Data as of 12:55pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | +45.55% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +5.49% |
| P/E ratio | 9.2 |
| Price/Sales | 4.37 |
| Price/Book | 3.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRNAModerna Inc | +2.28 | +1.76% |
| ILMNIllumina Inc | +8.51 | +2.29% |
| EXASExact Sciences Corp | -4.08 | -2.77% |
| ---- |
Data as of 12:58pm ET, 01/15/2021
Financials
| Next reporting date | February 3, 2021 |
| EPS forecast (this quarter) | $4.82 |
| Annual revenue (last year) | $12.7B |
| Annual profit (last year) | $5.9B |
| Net profit margin | 46.32% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
